At the heart of the article is the work of our Research and Development (R&D) department, which ensures that all processes within Medical Remanufacturing comply with regulatory requirements – including the EU Medical Device Regulation (MDR), the Implementing Regulation (EU) 2020/1207, and additional national provisions.
Our experts develop processes, testing methods, and technical solutions that enable safe, efficient, and resource-conserving reprocessing.
Using the example of electrophysiology catheters, we demonstrate how this approach proves successful in practice. Like many other complex and costly medical devices, these catheters are designated by their manufacturers as single-use products — a model that is resource-intensive, expensive, and environmentally questionable.
A study by Fraunhofer UMSICHT shows that reprocessing can reduce the carbon footprint by more than 50 % and resource consumption by over 28 % compared to new production.
This clearly illustrates the potential of Medical Remanufacturing to create a more sustainable healthcare system – without compromising on safety or functionality.
Read the full article here: Klinergie Magazin 2025
We are also proud to support the Viamedica Foundation as a funding partner. Learn more about the initiative here.
